Viscosupplementation MarketThe global viscosupplementation market is projected to reach US$ 2,167.3 million in 2024. The viscosupplementation demand is expected to witness a robust CAGR of 5.7% from 2024 to 2034. By 2034, the sales of viscosupplementation are anticipated to attain a valuation of US$ 3,777.4 million..
/PRNewswire/ Singapore-headquartered Juniper Biologics Pte Ltd, a science-led healthcare company focused on commercialising novel therapies, was awarded.
JUNIPER BIOLOGICS WINS M&A AWARD 2022 BY ACQUISITION INTERNATIONAL - PRN India News webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Juniper Biologics, a science-led healthcare company focused on researching, developing and commercializing novel therapies announced today that.
$600 million USD acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa